Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Kim, D.W.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(5)
+
-
Metadata Only
(3)
+
-
Creation Date
2012
(2)
+
-
2020
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Topic
NSCLC
(2)
+
-
Author
Kim, D.W.
(8)
+
-
Kim, S.W.
(4)
+
-
Cho, B.C.
(3)
+
-
Novello, S.
(3)
+
-
Smit, E.F.
(3)
+
-
Aglietta, M.
(2)
+
-
Ahn, M.J.
(2)
+
-
Araki, N.
(2)
+
-
Baas, P.
(2)
+
-
Beppu, Y.
(2)
+
-
Blay, J.Y.
(2)
+
-
Casali, P.G.
(2)
+
-
Cesne, A. le
(2)
+
-
Chawla, S.P.
(2)
+
-
Forster, M.D.
(2)
+
-
Garon, E.B.
(2)
+
-
Gelderblom, H.
(2)
+
-
Graaf, W.T.A. van der
(2)
+
-
Gubens, M.A.
(2)
+
-
Han, J.Y.
(2)
+
-
Herbst, R.S.
(2)
+
-
Hodge, R.
(2)
+
-
Hohenberger, P.
(2)
+
-
Jensen, E.H.
(2)
+
-
Judson, I.R.
(2)
+
-
Leighl, N.B.
(2)
+
-
Majem, M.
(2)
+
-
Marreaud, S.
(2)
+
-
Monnet, I.
(2)
+
-
Ouali, M.
(2)
+
-
Perez-Gracia, J.L.
(2)
+
-
Samkari, A.
(2)
+
-
Schoffski, P.
(2)
+
-
Staddon, A.P.
(2)
+
-
Su, W.C.
(2)
+
-
Yang, J.C.H.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small-cell lung cancer
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer
Five year survival update from KEYNOTE-010
Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1-positive, advanced non-small-cell lung cancer in the KEYNOTE-010 study
Brigatinib in crizotinib-refractory ALK+ NSCLC
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study
PALETTE: Final overall survival (OS) data and predictive factors for OS of EORTC 62072/GSK VEG110727, a randomized double-blind phase III trial of pazopanib versus placebo in advanced soft tissue sarcoma (STS) patients
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
